UK regulator to phase out Tavneos after finding trial data unreliable
Britain's MHRA suspended the use and sale of Tavneos (Avacopan Vifor) for new patients after deeming the pivotal trial data unreliable, with a six-month window for continuing treatment and a planned UK market revocation by March 1, 2027. Amgen and CSL Vifor dispute the decision, arguing that the broader evidence supports the drug's benefits, while regulators in the EU and US have also flagged concerns about data reliability and potential withdrawals.
Health · 7 sources · Sep 9, 2026Read it
The journal
Open the journal →The conversation starts in the journal — be the first to post.
About Amgen
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
Everything about Amgen →- Country
- United States
- Headquarters
- Thousand Oaks
- Inception
- 1980
- Website
- http://www.amgen.com/